NasdaqGM:MTBC.P

Stock Analysis Report

Executive Summary

MTBC, Inc., a healthcare information technology company, provides an integrated suite of Web-based solutions and related business services to healthcare providers primarily in the United States.

Snowflake

Fundamentals

Flawless balance sheet and fair value.


Similar Companies

Share Price & News

How has MTBC's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

0.07%

NasdaqGM:MTBC.P

2.1%

US Healthcare Services

1.1%

US Market


1 Year Return

-1.8%

NasdaqGM:MTBC.P

7.7%

US Healthcare Services

2.1%

US Market

MTBC.P underperformed the Healthcare Services industry which returned 6.6% over the past year.

MTBC.P underperformed the Market in United States of America which returned 2% over the past year.


Share holder returns

MTBC.PIndustryMarket
7 Day0.07%2.1%1.1%
30 Day0.5%-4.7%3.7%
90 Day-2.3%-4.6%2.3%
1 Year8.8%-1.8%7.7%7.7%4.4%2.1%
3 Year38.9%1.2%51.1%50.8%47.0%37.4%
5 Yearn/a49.2%48.3%61.6%43.8%

Price Volatility Vs. Market

How volatile is MTBC's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is MTBC undervalued based on future cash flows and its price relative to the stock market?

>50%

Discount to future cash flow value


Intrinsic Value Based on Future Cash Flows

MTBC's share price is below the future cash flow value, and at a moderate discount (> 20%).

MTBC's share price is below the future cash flow value, and at a substantial discount (> 40%).


Price Based on Earnings

MTBC is loss making, we can't compare its value to the US Healthcare Services industry average.

MTBC is loss making, we can't compare the value of its earnings to the United States of America market.


Price Based on Expected Growth

Unable to calculate PEG ratio for MTBC, we can't assess if its growth is good value.


Price Based on Value of Assets

MTBC is good value based on assets compared to the US Healthcare Services industry average.


Next Steps

Future Growth

How is MTBC expected to perform in the next 1 to 3 years based on estimates from 3 analysts?

94.3%

Forecasted annual earnings growth


Earnings and Revenue Growth Estimates


Future Annual Growth Analysis

MTBC's revenue is expected to grow by 4.9% yearly, however this is not considered high growth (20% yearly).

MTBC is not considered high growth as it is expected to be loss making for the next 1-3 years.

MTBC's revenue growth is positive but not above the United States of America market average.

Unable to compare MTBC's earnings growth to the United States of America market average as it is expected to be loss making during the next 1-3 years.

Unable to compare MTBC's earnings growth to the low risk savings rate as it is expected to be loss making during the next 1-3 years.


Earnings per Share Growth Estimates


Future Return on Equity

Unable to establish if MTBC will efficiently use shareholders’ funds in the future without estimates of Return on Equity.


Next Steps

Past Performance

How has MTBC performed over the past 5 years?

-14.1%

Historical annual earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

MTBC does not make a profit and their year on year earnings growth rate was negative over the past 5 years.

Unable to compare MTBC's 1-year earnings growth to the 5-year average as it is not currently profitable.

Unable to compare MTBC's 1-year growth to the US Healthcare Services industry average as it is not currently profitable.


Return on Equity

It is difficult to establish if MTBC has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.


Return on Assets

It is difficult to establish if MTBC has efficiently used its assets last year compared to the US Healthcare Services industry average (Return on Assets) as it is loss-making.


Return on Capital Employed

It is difficult to establish if MTBC improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.


Next Steps

Financial Health

How is MTBC's financial position?


Financial Position Analysis

MTBC is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.

MTBC's cash and other short term assets cover its long term commitments.


Debt to Equity History and Analysis

MTBC's level of debt (0.9%) compared to net worth is satisfactory (less than 40%).

MTBC had negative shareholder equity 5 years ago, it is now positive therefore their debt level has improved.


Balance Sheet

Low level of unsold assets.

Debt is covered by short term assets, assets are 70x debt.


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Whilst loss making MTBC has sufficient cash runway for more than 3 years if it maintains the current positive free cash flow level.

Whilst loss making MTBC has sufficient cash runway for more than 3 years, even with free cash flow being positive and shrinking by -109.9% per year.


Next Steps

Dividend

What is MTBC's current dividend yield, its reliability and sustainability?


Upcoming Dividend Payment

Purchase MTBC before the 'Buy Limit' to receive their next dividend payment.


Dividend Yield and Payments Analysis

Unable to evaluate MTBC's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.

Unable to evaluate MTBC's dividend against the top 25% market benchmark as the company has not reported any payouts.

Unable to perform a dividend volatility check as MTBC has not reported any payouts.

Unable to verify if MTBC's dividend has been increasing as the company has not reported any payouts.


Current Payout to Shareholders

Unable to calculate sustainability of dividends as MTBC has not reported any payouts.


Future Payout to Shareholders

Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.


Next Steps

Management

What is the CEO of MTBC's salary, the management and board of directors tenure and is there insider trading?

1.7yrs

Average management tenure


CEO

Stephen Snyder (42yo)

1.7yrs

Tenure

US$902,963

Compensation

Mr. Stephen A. Snyder has been Chief Executive Officer of MTBC Inc. since January 2018. Mr. Snyder served as the President of MTBC Inc. since September 2011 to January 1, 2018. Mr. Snyder served as the Chi ...


CEO Compensation Analysis

Stephen's remuneration is higher than average for companies of similar size in United States of America.

Stephen's compensation has increased whilst company is loss making.


Management Age and Tenure

1.7yrs

Average Tenure

51yo

Average Age

The average tenure for the MTBC management team is less than 2 years, this suggests a new team.


Board Age and Tenure

5.8yrs

Average Tenure

65yo

Average Age

The tenure for the MTBC board of directors is about average.


Insider Trading

No 3 month open market individual insider trading information.


Recent Insider Transactions

SellUS$124,53530 Mar 19
A. Chaudhry
EntityIndividual
Role
Member of the Board of Directors
President & Director
Shares4,680
Max PriceUS$26.61
SellUS$172,75730 Mar 19
Mahmud Haq
EntityIndividual
Role
Chairman of the Board
Founder & Executive Chairman
Shares6,480
Max PriceUS$26.66

Ownership Breakdown


Management Team

  • Mahmud Haq (60yo)

    Founder & Executive Chairman

    • Tenure: 18.7yrs
    • Compensation: US$867.04k
  • Bill Korn (62yo)

    Chief Financial Officer

    • Tenure: 6.2yrs
    • Compensation: US$720.74k
  • Stephen Snyder (42yo)

    CEO & Director

    • Tenure: 1.7yrs
    • Compensation: US$902.96k
  • Loraine Goetsch

    Division President

    • Tenure: 0yrs
  • Ryan Howard

    Special Adviser to Chief Executive Officer

    • Tenure: 1.4yrs
  • A. Chaudhry (42yo)

    President & Director

    • Tenure: 0.4yrs
  • Norman Roth (63yo)

    Principal Accounting Officer & Controller

    • Tenure: 0yrs
  • Shruti Patel (31yo)

    General Counsel & Corporate Secretary

    • Tenure: 2.8yrs
  • Rachel Grossinger

    Marketing Manager

    • Tenure: 0yrs

Board Members

  • Anne Busquet (69yo)

    Director

    • Tenure: 5.2yrs
    • Compensation: US$136.75k
  • Howard Clark (75yo)

    Vice Chairman & Director

    • Tenure: 0.4yrs
    • Compensation: US$146.75k
  • Mahmud Haq (60yo)

    Founder & Executive Chairman

    • Tenure: 18.7yrs
    • Compensation: US$867.04k
  • Stephen Snyder (42yo)

    CEO & Director

    • Tenure: 1.7yrs
    • Compensation: US$902.96k
  • Cameron Munter (65yo)

    Director

    • Tenure: 6.3yrs
    • Compensation: US$136.75k
  • John Daly (81yo)

    Director

    • Tenure: 5.8yrs
    • Compensation: US$136.75k
  • A. Chaudhry (42yo)

    President & Director

    • Tenure: 0.4yrs

Company Information

MTBC, Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: MTBC, Inc.
  • Ticker: MTBC.P
  • Exchange: NasdaqGM
  • Founded: 1999
  • Industry: Health Care Technology
  • Sector: Healthcare
  • Market Cap: US$51.502m
  • Shares outstanding: 12.03m
  • Website: https://www.mtbc.com

Number of Employees


Location

  • MTBC, Inc.
  • 7 Clyde Road
  • Somerset
  • New Jersey
  • 8873
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
MTBCNasdaqGM (Nasdaq Global Market)YesCommon SharesUSUSDJul 2014
MTBDB (Deutsche Boerse AG)YesCommon SharesDEEURJul 2014
MTBC.PNasdaqGM (Nasdaq Global Market)11% CUM PFD CL AUSUSDNov 2015

Biography

MTBC, Inc., a healthcare information technology company, provides an integrated suite of Web-based solutions and related business services to healthcare providers primarily in the United States. The compan ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/09/17 00:41
End of Day Share Price2019/09/16 00:00
Earnings2019/06/30
Annual Earnings2018/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.